Dental pulp stem cell population

Abstract

The present invention relates, for example, to a stem cell population derived from human deciduous dental pulp, the stem cell population being characterized in that 90% or more of the stem cell population is CD117-negative, CD73-positive, CD90-positive, and CD105-positive, and to a method for producing a stem cell population derived from human deciduous dental pulp, comprising the step of culturing cells isolated from the human deciduous dental pulp in a medium free of FBS (fetal bovine serum) in the presence of a human platelet lysate (hPL). The present invention also relates to an agent for preventing or treating cerebral palsy, comprising dental pulp stem cells, wherein the prevention or treatment agent is administered to a subject with symptoms of cerebral palsy.

Dependencies are inferred from the claim text.